WallStreetZenWallStreetZen

NYSE: DNA
Ginkgo Bioworks Holdings Inc Stock Forecast, Predictions & Price Target

Analyst price target for DNA

Based on 3 analysts offering 12 month price targets for Ginkgo Bioworks Holdings Inc.
Min Forecast
$1.10-14.73%
Avg Forecast
$2.20+70.54%
Max Forecast
$3.00+132.56%

Should I buy or sell DNA stock?

Based on 3 analysts offering ratings for Ginkgo Bioworks Holdings Inc.
Hold
Strong Buy
0 analysts 0%
Buy
1 analysts 33.33%
Hold
1 analysts 33.33%
Sell
0 analysts 0%
Strong Sell
1 analysts 33.33%

Be the first to know when Wall Street analysts revise their DNA stock forecasts and price targets.

DNA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-01
lockedlocked$00.00+00.00%2024-01-23
lockedlocked$00.00+00.00%2023-11-15

1 of 1

Forecast return on equity

Is DNA forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
34.96%

Forecast return on assets

Is DNA forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

DNA revenue forecast

What is DNA's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$262.9M+4.54%
Avg 2 year Forecast
$431.7M+71.69%
Avg 3 year Forecast
$611.6M+143.22%
DNA's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

DNA revenue growth forecast

How is DNA forecast to perform vs Biotechnology companies and vs the US market?
Company
34.24%
Industry
45.76%
Market
10.79%
DNA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
DNA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

DNA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
DNA$1.29$2.20+70.54%Hold
TGTX$17.96$27.50+53.12%Strong Buy
RCKT$30.53$55.83+82.88%Strong Buy
NMRA$18.05$22.00+21.88%Strong Buy
KYMR$43.50$40.25-7.47%Buy

Ginkgo Bioworks Holdings Stock Forecast FAQ

Is Ginkgo Bioworks Holdings Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NYSE: DNA) stock is to Hold DNA stock.

Out of 3 analysts, 0 (0%) are recommending DNA as a Strong Buy, 1 (33.33%) are recommending DNA as a Buy, 1 (33.33%) are recommending DNA as a Hold, 0 (0%) are recommending DNA as a Sell, and 1 (33.33%) are recommending DNA as a Strong Sell.

If you're new to stock investing, here's how to buy Ginkgo Bioworks Holdings stock.

What is DNA's revenue growth forecast for 2024-2026?

(NYSE: DNA) Ginkgo Bioworks Holdings's forecast annual revenue growth rate of 34.24% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 45.76%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.79%.

Ginkgo Bioworks Holdings's revenue in 2024 is $251,455,000.On average, 3 Wall Street analysts forecast DNA's revenue for 2024 to be $565,785,213,495, with the lowest DNA revenue forecast at $501,508,218,138, and the highest DNA revenue forecast at $643,566,340,014. On average, 2 Wall Street analysts forecast DNA's revenue for 2025 to be $929,234,461,128, with the lowest DNA revenue forecast at $862,555,392,073, and the highest DNA revenue forecast at $995,913,530,182.

In 2026, DNA is forecast to generate $1,316,405,262,718 in revenue, with the lowest revenue forecast at $1,316,405,262,718 and the highest revenue forecast at $1,316,405,262,718.

What is DNA's forecast return on assets (ROA) for 2024-2027?

(NYSE: DNA) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is DNA's Price Target?

According to 3 Wall Street analysts that have issued a 1 year DNA price target, the average DNA price target is $2.20, with the highest DNA stock price forecast at $3.00 and the lowest DNA stock price forecast at $1.10.

On average, Wall Street analysts predict that Ginkgo Bioworks Holdings's share price could reach $2.20 by Mar 1, 2025. The average Ginkgo Bioworks Holdings stock price prediction forecasts a potential upside of 70.54% from the current DNA share price of $1.29.

What is DNA's forecast return on equity (ROE) for 2024-2027?

(NYSE: DNA) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.